線維筋痛薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Fibromyalgia Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03637 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、線維筋痛薬の世界市場について調査・分析し、線維筋痛薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（セロトニンノルエピネフリン再取り込み阻害剤、GABAアナログ、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の線維筋痛薬市場動向 ・主要企業別マーケットシェア ・線維筋痛薬の種類別市場規模2014-2019 （セロトニンノルエピネフリン再取り込み阻害剤、GABAアナログ、その他） ・線維筋痛薬の用途別市場規模2014-2019 （病院、診療所、その他） ・線維筋痛薬の北米市場：主要企業・種類別/用途別市場規模 ・線維筋痛薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・線維筋痛薬の中国市場：主要企業・種類別/用途別市場規模 ・線維筋痛薬の日本国内市場：主要企業・種類別/用途別市場規模 ・線維筋痛薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・線維筋痛薬のインド市場：主要企業・種類別/用途別市場規模 ・線維筋痛薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Eli Lilly、Actavis、Merck Sharp and Dohme、Daiichi Sankyo、Innovative Med Concepts、Meda、Meiji Seika、Switch Biotech、Theravance、Zynerba Pharmaceuticals、Tonix Pharmaceuticals Holding Corp. (TNXP)） ・線維筋痛薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market.
In 2018, the global Fibromyalgia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Fibromyalgia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fibromyalgia Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)

Market segment by Type, the product can be split into
Serotonin Norepinephrine Reuptake Inhibitors
GABA Analogs
Other

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Fibromyalgia Drugs status, future forecast, growth opportunity, key market and key players.
To present the Fibromyalgia Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Fibromyalgia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fibromyalgia Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Serotonin Norepinephrine Reuptake Inhibitors
1.4.3 GABA Analogs
1.4.4 Other
1.5 Market by Application
1.5.1 Global Fibromyalgia Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Fibromyalgia Drugs Market Size
2.2 Fibromyalgia Drugs Growth Trends by Regions
2.2.1 Fibromyalgia Drugs Market Size by Regions (2014-2025)
2.2.2 Fibromyalgia Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Fibromyalgia Drugs Market Size by Manufacturers
3.1.1 Global Fibromyalgia Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Fibromyalgia Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Fibromyalgia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Fibromyalgia Drugs Key Players Head office and Area Served
3.3 Key Players Fibromyalgia Drugs Product/Solution/Service
3.4 Date of Enter into Fibromyalgia Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Fibromyalgia Drugs Market Size by Type (2014-2019)
4.2 Global Fibromyalgia Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Fibromyalgia Drugs Market Size (2014-2019)
5.2 Fibromyalgia Drugs Key Players in United States
5.3 United States Fibromyalgia Drugs Market Size by Type
5.4 United States Fibromyalgia Drugs Market Size by Application

6 Europe
6.1 Europe Fibromyalgia Drugs Market Size (2014-2019)
6.2 Fibromyalgia Drugs Key Players in Europe
6.3 Europe Fibromyalgia Drugs Market Size by Type
6.4 Europe Fibromyalgia Drugs Market Size by Application

7 China
7.1 China Fibromyalgia Drugs Market Size (2014-2019)
7.2 Fibromyalgia Drugs Key Players in China
7.3 China Fibromyalgia Drugs Market Size by Type
7.4 China Fibromyalgia Drugs Market Size by Application

8 Japan
8.1 Japan Fibromyalgia Drugs Market Size (2014-2019)
8.2 Fibromyalgia Drugs Key Players in Japan
8.3 Japan Fibromyalgia Drugs Market Size by Type
8.4 Japan Fibromyalgia Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Fibromyalgia Drugs Market Size (2014-2019)
9.2 Fibromyalgia Drugs Key Players in Southeast Asia
9.3 Southeast Asia Fibromyalgia Drugs Market Size by Type
9.4 Southeast Asia Fibromyalgia Drugs Market Size by Application

10 India
10.1 India Fibromyalgia Drugs Market Size (2014-2019)
10.2 Fibromyalgia Drugs Key Players in India
10.3 India Fibromyalgia Drugs Market Size by Type
10.4 India Fibromyalgia Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Fibromyalgia Drugs Market Size (2014-2019)
11.2 Fibromyalgia Drugs Key Players in Central & South America
11.3 Central & South America Fibromyalgia Drugs Market Size by Type
11.4 Central & South America Fibromyalgia Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fibromyalgia Drugs Introduction
12.1.4 Pfizer Revenue in Fibromyalgia Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fibromyalgia Drugs Introduction
12.2.4 Eli Lilly Revenue in Fibromyalgia Drugs Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Actavis
12.3.1 Actavis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fibromyalgia Drugs Introduction
12.3.4 Actavis Revenue in Fibromyalgia Drugs Business (2014-2019)
12.3.5 Actavis Recent Development
12.4 Merck Sharp and Dohme
12.4.1 Merck Sharp and Dohme Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fibromyalgia Drugs Introduction
12.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2014-2019)
12.4.5 Merck Sharp and Dohme Recent Development
12.5 Daiichi Sankyo
12.5.1 Daiichi Sankyo Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fibromyalgia Drugs Introduction
12.5.4 Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2014-2019)
12.5.5 Daiichi Sankyo Recent Development
12.6 Innovative Med Concepts
12.6.1 Innovative Med Concepts Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fibromyalgia Drugs Introduction
12.6.4 Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2014-2019)
12.6.5 Innovative Med Concepts Recent Development
12.7 Meda
12.7.1 Meda Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fibromyalgia Drugs Introduction
12.7.4 Meda Revenue in Fibromyalgia Drugs Business (2014-2019)
12.7.5 Meda Recent Development
12.8 Meiji Seika
12.8.1 Meiji Seika Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fibromyalgia Drugs Introduction
12.8.4 Meiji Seika Revenue in Fibromyalgia Drugs Business (2014-2019)
12.8.5 Meiji Seika Recent Development
12.9 Switch Biotech
12.9.1 Switch Biotech Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fibromyalgia Drugs Introduction
12.9.4 Switch Biotech Revenue in Fibromyalgia Drugs Business (2014-2019)
12.9.5 Switch Biotech Recent Development
12.10 Theravance
12.10.1 Theravance Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fibromyalgia Drugs Introduction
12.10.4 Theravance Revenue in Fibromyalgia Drugs Business (2014-2019)
12.10.5 Theravance Recent Development
12.11 Zynerba Pharmaceuticals
12.12 Tonix Pharmaceuticals Holding Corp. (TNXP)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Fibromyalgia Drugs Key Market Segments
Table Key Players Fibromyalgia Drugs Covered
Table Global Fibromyalgia Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Fibromyalgia Drugs Market Size Market Share by Type 2014-2025
Figure Serotonin Norepinephrine Reuptake Inhibitors Figures
Table Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Figure GABA Analogs Figures
Table Key Players of GABA Analogs
Figure Other Figures
Table Key Players of Other
Table Global Fibromyalgia Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Fibromyalgia Drugs Report Years Considered
Table Global Fibromyalgia Drugs Market Size 2014-2025 (Million US$)
Figure Global Fibromyalgia Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Fibromyalgia Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Fibromyalgia Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Fibromyalgia Drugs Market Share by Regions 2014-2019
Figure Global Fibromyalgia Drugs Market Share by Regions 2014-2019
Figure Global Fibromyalgia Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Fibromyalgia Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Fibromyalgia Drugs Market Share by Manufacturers (2014-2019)
Figure Global Fibromyalgia Drugs Market Share by Manufacturers in 2018
Table Global Fibromyalgia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Fibromyalgia Drugs Product/Solution/Service
Table Date of Enter into Fibromyalgia Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Fibromyalgia Drugs Market Size Share by Type (2014-2019)
Figure Global Fibromyalgia Drugs Market Size Market Share by Type (2014-2019)
Table Global Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Fibromyalgia Drugs Market Size Share by Application (2014-2019)
Figure Global Fibromyalgia Drugs Market Size Market Share by Application (2014-2019)
Figure Global Fibromyalgia Drugs Revenue Market Share by Application in 2018
Figure United States Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table United States Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Fibromyalgia Drugs Market Share by Type (2014-2019)
Table United States Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Fibromyalgia Drugs Market Share by Application (2014-2019)
Figure Europe Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table Europe Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Fibromyalgia Drugs Market Share by Type (2014-2019)
Table Europe Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Fibromyalgia Drugs Market Share by Application (2014-2019)
Figure China Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table China Fibromyalgia Drugs Market Size by Type (2014-20189) (Million US$)
Table China Fibromyalgia Drugs Market Share by Type (2014-2019)
Table China Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table China Fibromyalgia Drugs Market Share by Application (2014-2019)
Figure Japan Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table Japan Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Fibromyalgia Drugs Market Share by Type (2014-2019)
Table Japan Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Fibromyalgia Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table Southeast Asia Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Fibromyalgia Drugs Market Share by Type (2014-2019)
Table Southeast Asia Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Fibromyalgia Drugs Market Share by Application (2014-2019)
Figure India Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table India Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table India Fibromyalgia Drugs Market Share by Type (2014-2019)
Table India Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table India Fibromyalgia Drugs Market Share by Application (2014-2019)
Figure Central & South America Fibromyalgia Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Fibromyalgia Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Fibromyalgia Drugs Market Share (2018-2019)
Table Central & South America Fibromyalgia Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Fibromyalgia Drugs Market Share by Type (2014-2019)
Table Central & South America Fibromyalgia Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Fibromyalgia Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Fibromyalgia Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table Actavis Company Details
Table Actavis Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Actavis Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Actavis Recent Development
Table Merck Sharp and Dohme Company Details
Table Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Merck Sharp and Dohme Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Daiichi Sankyo Recent Development
Table Innovative Med Concepts Company Details
Table Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Innovative Med Concepts Recent Development
Table Meda Company Details
Table Meda Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Meda Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Meda Recent Development
Table Meiji Seika Company Details
Table Meiji Seika Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Meiji Seika Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Meiji Seika Recent Development
Table Switch Biotech Company Details
Table Switch Biotech Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Switch Biotech Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Switch Biotech Recent Development
Table Theravance Company Details
Table Theravance Revenue in Fibromyalgia Drugs Business (2014-2019)(Million US$)
Figure Theravance Revenue Growth Rate in Fibromyalgia Drugs Business (2014-2019)
Table Theravance Recent Development
Table Zynerba Pharmaceuticals Company Details
Table Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
Table Global Fibromyalgia Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Fibromyalgia Drugs Market Size Share by Regions (2019-2025)
Figure Global Fibromyalgia Drugs Market Size Share by Regions in 2025
Figure United States Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Fibromyalgia Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Fibromyalgia Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Fibromyalgia Drugs Market Size by Product (2019-2025)
Figure Global Fibromyalgia Drugs Market Size by Product in 2025
Table Global Fibromyalgia Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Fibromyalgia Drugs Market Size by Application (2019-2025)
Figure Global Fibromyalgia Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---